The Patent Finder

Onkimmune Limited

Also on record
Records under this name other than the patents Onkimmune Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 3 of 3 · Back to Onkimmune Limited

PatentTitleStatus Expires Confidence
US 10,906,951Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,799,536Method of treating multiple myeloma using natural killer cells expressing a chimeric antigen receptor for CD38
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,034,925Modified Natural Killer Cells and Natural Killer Cell Lines Having Increased Cytotoxicity
Formerly held
Lapsed on the fee record
Ended Jul 31, 2026 · High confidence
Lapsed on the fee recordEnded Jul 31, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited